Search Results - Yuliya Lytvyn

Targeting Interleukin 13 for the Treatment of Atopic Dermatitis by Yuliya Lytvyn, Melinda Gooderham

Connect to this object online.

Dermatology: how to manage psoriasis and recognize differences in pathophysiology and presentation in patients with skin of colour by Yuliya Lytvyn, Muskaan Sachdeva, Asfandyar Mufti, Jensen Yeung

Connect to this object online.

Efficacy and Safety of Upadacitinib for Management of Moderate-to-Severe Atopic Dermatitis: An Evidence-Based Review by Yuliya Lytvyn, Asfandyar Mufti, Abrahim Abduelmula, Muskaan Sachdeva, Khalad Maliyar, Jorge R. Georgakopoulos, Jensen Yeung

Connect to this object online.

Comparing the frequency of isotretinoin-induced hair loss at <0.5-mg/kg/d versus ≥0.5-mg/kg/d dosing in acne patients: A systematic reviewCapsule Summary by Yuliya Lytvyn, PhD, Katherine McDonald, MD, Asfandyar Mufti, MD, Jennifer Beecker, MD, CCFP (EM)

Connect to this object online.

Drug survival of guselkumab in patients with plaque psoriasis: A 2 year retrospective, multicenter study by Yuliya Lytvyn, PhD, Hiba Zaaroura, MD, Asfandyar Mufti, MD, Shaikhah AlAbdulrazzaq, MD, Jensen Yeung, MD, FRCPC

Connect to this object online.

Treatment outcomes in patients with papuloerythroderma of Ofuji: A systematic review by Asfandyar Mufti, MD, Yuliya Lytvyn, PhD, Abrahim Abduelmula, BScN, Patrick Kim, BHSc, Muskaan Sachdeva, BHSc, Jensen Yeung, MD, FRCPC

Connect to this object online.

Efficacy and safety of risankizumab for moderate-to-severe plaque psoriasis in clinical practice: A 16-week Canadian retrospective multicenter cohort study by Yuliya Lytvyn, PhD, Asfandyar Mufti, MD, Hiba Zaaroura, MD, Muskaan Sachdeva, BHSc, Justin D. Lu, MSc, Brian D. Rankin, PhD, Vimal H. Prajapati, MD, Ronald Vender, MD, Jensen Yeung, MD, FRCPC

Connect to this object online.